Kidney Cancer Market Analysis by Type (renal cell cancer, transitional cell cancer, and Wilms tumor), by Treatment Modalities (Type of surgery, Targeted therapy, Immunotherapy, Radiation therapy, Emerging therapies), by End-Users (Hospitals, Homecare, Specialty Clinics, Others) and by Region: Global Forecast, 2024 - 2034
- PUBLISHED ON
- 2024-04-22
- NO OF PAGES
- 191
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Kidney Cancer market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.
SOURCE: We Market Research
Renal cell
carcinoma, also referred to as kidney cancer, is a type of cancer that starts
in the kidneys, which are essential organs in charge of eliminating waste
materials from the body through the generation of urine and filtering blood.
The lining of the kidneys' tiny tubes, or tubules, is where kidney cancer
usually starts. Kidney cancer's precise etiology is frequently unknown, while
risk factors like smoking, obesity, high blood pressure, and family history may
make the disease more likely to occur. Kidney cancer can cause fever, exhaustion,
weight loss, back pain, stomach pain, and blood in the urine. Treatment options
vary based on the disease's stage and extent and may include immunotherapy,
surgery, targeted therapy, and occasionally radiation therapy. Kidney cancer
management and surveillance depend on routine medical check-ups.
Increasing incidence of the disease, improvements in imaging and biomarker technologies, and cutting-edge therapeutic options like targeted and immunotherapies are driving the global kidney cancer market. Strong research and development initiatives aimed at comprehending the biology of kidney cancer and creating novel treatments propel the market's expansion. The growth of the market is facilitated by initiatives in healthcare, government regulations that are supportive, and increasing patient awareness. Technological developments in surgery and medical equipment also lead to better treatment results. This dynamic ecosystem is the result of a global effort to solve kidney cancer's difficulties and improve patient treatment.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD XX Million |
|
Market Forecast in 2034 |
USD XX Million |
|
CAGR % 2024-2034 |
XX % |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
by Type, by Treatment Modalities, by End-Users and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Kidney Cancer Industry: Dynamics & Restrains
Market opportunity:
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Kidney Cancer Segmentation
Market- By Type Analysis
By Type, the Kidney Cancer Market is Categories into renal cell cancer, transitional cell cancer, and Wilms tumor. The renal cell cancer segment accounts for the largest share of around 82% in 2024.
The renal cell carcinoma (RCC) subsegment
holds a dominating position in the worldwide kidney cancer market, primarily
due to the increased demand for expensive and novel medications created by
breakthroughs in RCC diagnosis and treatment.
The
following segments are part of an in-depth analysis of the global Kidney Cancer
market:
|
Market Segments |
|
|
By Treatment
Modalities |
·
Type of surgery ·
Targeted therapy ·
Immunotherapy ·
Radiation therapy ·
Emerging therapies |
|
By End-Users |
·
Hospitals ·
Homecare ·
Specialty Clinics ·
Others |
Kidney Cancer Industry: Regional Analysis
North America Market Forecast
North America dominate the Kidney Cancer Market with the highest revenue generating market with share of more than 49%. North America holds a significant market share for kidney cancer due to factors such as a highly developed healthcare system, a high incidence of kidney cancer, and increased awareness about early detection and treatment options. Novel treatments are released as a consequence of extensive research and development efforts in the field. Benefitous reimbursement policies and increased investment on oncology research are further factors propelling this market's growth in North America.
Europe Market Statistics
Europe is now a
major player in the renal cancer market due to a growing elderly population and
a rise in kidney cancer cases. The presence of eminent research institutions
and pharmaceutical companies fosters the development of novel therapeutic
options. In addition, government initiatives that raise cancer awareness and facilitate
access to treatment are crucial for the expansion of the industry across Europe.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Kidney Cancer market
during the forecast period. The kidney cancer market in the Asia Pacific area
is growing quickly, mostly as a result of better healthcare infrastructure,
rising disposable income, and rising healthcare costs. Another factor boosting
the industry is growing consumer knowledge of early diagnosis and treatment
options. Furthermore, market participants have ample opportunity to increase
their market share through successful market penetration tactics because to the
sizeable patient pool in nations such as China and India.
Key Market Players
The Kidney Cancer Market is dominated by a
few large companies, such as
·
Merck
·
Novartis
·
AstraZeneca
·
Bristol-Myers Squibb
·
Pfizer
·
Roche
·
Amgen
·
Argos Therapeutics
·
Aveo Pharmaceuticals
·
Bayer
·
Exelixis
·
Incyte
· Allergan
· Other
1.
Global
Kidney Cancer Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Kidney Cancer Market
Scope and Market Estimation
1.2.1. Global Kidney Cancer Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Kidney Cancer Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Component of Global Kidney
Cancer Market
1.3.2. Technology of Global Kidney
Cancer Market
1.3.3. End-user of Global Kidney Cancer
Market
1.3.4. Region of Global Kidney Cancer
Market
2.
Executive Summary
2.1. Global Kidney Cancer Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Kidney Cancer Market
Industry Development
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6. Value Chain / Ecosystem Analysis
2.7. Russia-Ukraine War Impacts
Analysis
2.8. Economic Downturn Analysis
2.9. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Kidney Cancer Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by
TYPE
4.1. Global Kidney Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034
4.1.1. Renal cell cancer
4.1.2. Transitional cell cancer
4.1.3. Wilms tumor
5.
Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by
Treatment Modalities
5.1. Global Kidney Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by Treatment Modalities, 2019 to 2034
5.1.1. Type of surgery
5.1.2. Targeted therapy
5.1.3. Immunotherapy
5.1.4. Radiation therapy
5.1.5. Emerging therapies
6.
Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by
End-user
6.1. Global Kidney Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by End-user,
2019 to 2034
6.1.1. Hospitals
6.1.2. Homecare
6.1.3. Specialty Clinics
6.1.4. Others
7.
Global Kidney Cancer Market Estimates & Forecast Trend Analysis,
by Region
7.1. Global Kidney Cancer Market
Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.
North
America Kidney Cancer Market: Estimates & Forecast Trend Analysis
8.1.
North
America Kidney Cancer Market Assessments & Key Findings
8.1.1. North America Kidney Cancer
Market Introduction
8.1.2. North America Kidney Cancer
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1. By TYPE
8.1.2.2. By Treatment
Modalities
8.1.2.3. By End-user
8.1.2.4. By Country
8.1.2.4.1. The U.S.
8.1.2.4.2. Canada
8.1.2.4.3. Mexico
9.
Europe
Kidney Cancer Market: Estimates & Forecast Trend Analysis
9.1. Europe Kidney Cancer Market
Assessments & Key Findings
9.1.1. Europe Kidney Cancer Market
Introduction
9.1.2. Europe Kidney Cancer Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1. By TYPE
9.1.2.2. By Treatment
Modalities
9.1.2.3. By End-user
9.1.2.4.
By
Country
9.1.2.4.1. Germany
9.1.2.4.2. U.K.
9.1.2.4.3. France
9.1.2.4.4. Italy
9.1.2.4.5. Spain
9.1.2.4.6. Russia
9.1.2.4.7. Rest of Europe
10. Asia Pacific Kidney
Cancer Market: Estimates & Forecast
Trend Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1. Asia Pacific Kidney Cancer
Market Introduction
10.1.2. Asia Pacific Kidney Cancer
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By TYPE
10.1.2.2. By Treatment
Modalities
10.1.2.3. By End-user
10.1.2.4. By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Kidney
Cancer Market: Estimates & Forecast
Trend Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1. Middle
East & Africa Kidney
Cancer Market Introduction
11.1.2. Middle
East & Africa Kidney
Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By TYPE
11.1.2.2. By Treatment
Modalities
11.1.2.3. By End-user
11.1.2.4. By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Kidney Cancer Market: Estimates &
Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1. South America Kidney Cancer
Market Introduction
12.1.2. South America Kidney Cancer
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By TYPE
12.1.2.2. By Treatment
Modalities
12.1.2.3. By End-user
12.1.2.4. By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Kidney Cancer Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Kidney Cancer Market
Competition White Space Analysis, By End-user
13.3. Global Kidney Cancer Market
Competition Heat Map Analysis, By End-user
13.4. Global Kidney Cancer Market
Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.
Merck
14.1.1. Company Overview & Key Stats
14.1.2. Financial Performance & KPIs
14.1.3. Product Portfolio
14.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
14.2. Novartis
14.3. AstraZeneca
14.4. Bristol-Myers
Squibb
14.5. Pfizer
14.6. Roche
14.7. Amgen
14.8. Argos
Therapeutics
14.9. Aveo
Pharmaceuticals
14.10. Bayer
14.11. Exelixis
14.12. Incyte
14.13. Allergan
14.14. Others
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research
Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Kidney Cancer Market in 2024?
Kidney Cancer Market was valued at USD XX Million in 2024.
What is the growth rate for the Kidney Cancer Market?
Kidney Cancer Market size will increase at approximate CAGR of XX% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Kidney Cancer Market Are Merck, Novartis, AstraZeneca, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Argos Therapeutics, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Allergan and others.
Which region dominates the Kidney Cancer Market?
North America dominates the market with an active share of 49%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI